MarketPeel
Chief Business Officer
Fri, Sep 27, 2024
Sep 27
exercised or converted securities in JANX
50,000 shares @ $0.00
Decreased holdings by -33.20%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
JANXJanux Therapeutics, Inc.
HealthcareBiotechnology
1D0.00%
1W+7.88%
1M+13.44%
3M
6M
1Y

Recent insider activity at JANX

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback